Table 2 Inflammatory markers (Median, IQR) and NT–proBNP concentrations (Median, IQR) in patients and control dogs
From: Inflammation and its association with oxidative stress in dogs with heart failure
Control (n = 10) | No CHF (n = 11) | CHF (n = 26) | |
|---|---|---|---|
TNF-α (pg/mL) | 3.90; 3.90–10.50 | 3.90; 3.90–3.90 | 3.90; 6.85–11.90a |
IL-6 (pg/mL) | 31.3; 31.3–31.3 | 31.3; 31.3–31.3 | 31.3; 31.3–31.3 |
CRP (mg/L) | 0.90; 0.78–1.33 | 1.45; 0.57–7.74 | 3.53; 1.10–13.18b |
WBC (× 109/L) | 6.2; 5.2–8.2 | 7.7; 6.3–8.9 | 10.5; 8.1–13.6c |
NEUT (× 109/L) | 3.4; 2.8–5.2 | 5.2; 3.2–6.8 | 7.2; 5.7–10.3b |
Neutrophils (%) | 57.3; 51.2–60.7d | 66.3; 63.2–75.9 | 69.5; 61.3–73.5 |
LYMPH (× 109/L) | 1.83; 1.47–2.35 | 1.28; 1.18–2.26 | 1.96; 1.57–2.89a |
Lymphocytes (%) | 30.7; 24.8–35.0d | 17.4; 14.2–26.0 | 20.0; 14.7–24.6 |
MONO (× 109/L) | 0.28; 0.21–0.39 | 0.42; 0.28–0.55 | 0.60; 0.44–0.84c |
Monocytes (%) | 4.2; 3.6–6.4 | 5.5; 4.5–6.2 | 5.7; 4.3–7.7 |
NT–proBNP (pmol/L) | 822; 507–1201 | 1207; 927–3086 | 4773; 2828–8529c |